US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US7767422B2
(en)
*
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
DE60035196T2
(de)
*
|
1999-06-28 |
2008-02-21 |
Source Precision Medicine, Inc., Boulder |
Verfahren zum Charakterisieren von biologischen Bedingungen, die kalibrierte Genexpressionsprofile verwenden
|
US6586177B1
(en)
*
|
1999-09-08 |
2003-07-01 |
Exact Sciences Corporation |
Methods for disease detection
|
US6919174B1
(en)
*
|
1999-12-07 |
2005-07-19 |
Exact Sciences Corporation |
Methods for disease detection
|
GB0009784D0
(en)
*
|
2000-04-20 |
2000-06-07 |
Simeg Limited |
Methods for clinical diagnosis
|
US7083924B2
(en)
|
2000-07-10 |
2006-08-01 |
Btg International Limited |
Diagnostic method for the identification of foetal DNA in a material sample
|
GB0016742D0
(en)
*
|
2000-07-10 |
2000-08-30 |
Simeg Limited |
Diagnostic method
|
EP1354060B1
(en)
*
|
2000-08-28 |
2011-02-09 |
Oncomedx, Inc. |
5t4 rna in plasma and serum as a marker for neoplastic disease
|
US6664056B2
(en)
*
|
2000-10-17 |
2003-12-16 |
The Chinese University Of Hong Kong |
Non-invasive prenatal monitoring
|
US20090226915A1
(en)
*
|
2001-01-24 |
2009-09-10 |
Health Discovery Corporation |
Methods for Screening, Predicting and Monitoring Prostate Cancer
|
CA2753372C
(en)
*
|
2001-06-14 |
2018-08-07 |
The Regents Of The University Of California |
Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
|
US6927028B2
(en)
|
2001-08-31 |
2005-08-09 |
Chinese University Of Hong Kong |
Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
|
EP1468104A4
(en)
*
|
2002-01-18 |
2006-02-01 |
Genzyme Corp |
METHODS FOR DETECTION OF FETAL DNA AND QUANTIFICATION OF ALLELES
|
US7776524B2
(en)
|
2002-02-15 |
2010-08-17 |
Genzyme Corporation |
Methods for analysis of molecular events
|
IL163600A0
(en)
|
2002-03-01 |
2005-12-18 |
Ravgen Inc |
Methods for detection of genetic disorders
|
US6977162B2
(en)
*
|
2002-03-01 |
2005-12-20 |
Ravgen, Inc. |
Rapid analysis of variations in a genome
|
US20070178478A1
(en)
*
|
2002-05-08 |
2007-08-02 |
Dhallan Ravinder S |
Methods for detection of genetic disorders
|
US7727720B2
(en)
*
|
2002-05-08 |
2010-06-01 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
US7442506B2
(en)
*
|
2002-05-08 |
2008-10-28 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
WO2004029221A2
(en)
|
2002-09-27 |
2004-04-08 |
The General Hospital Corporation |
Microfluidic device for cell separation and uses thereof
|
DK1816461T3
(da)
|
2002-10-16 |
2020-04-14 |
Streck Laboratories Inc |
Fremgangsmåde og indretning til indsamling og sikring af celler til brug for analyse
|
DE10254601A1
(de)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
EP1581629B1
(en)
*
|
2002-12-06 |
2015-04-01 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
|
CN100379882C
(zh)
|
2003-01-17 |
2008-04-09 |
香港中文大学 |
作为妊娠相关病症的诊断标志物的循环mRNA
|
WO2005023091A2
(en)
*
|
2003-09-05 |
2005-03-17 |
The Trustees Of Boston University |
Method for non-invasive prenatal diagnosis
|
EP1524321B2
(en)
|
2003-10-16 |
2014-07-23 |
Sequenom, Inc. |
Non-invasive detection of fetal genetic traits
|
EP1706720A4
(en)
*
|
2003-10-31 |
2007-02-28 |
Vitatex Inc |
BLOOD TEST PROTOTYPES AND METHOD FOR DETECTING CIRCULATING TUMOR AND ENDOTHELIAL CELLS
|
US7252946B2
(en)
*
|
2004-01-27 |
2007-08-07 |
Zoragen, Inc. |
Nucleic acid detection
|
US9186685B2
(en)
|
2012-01-13 |
2015-11-17 |
The University Of British Columbia |
Multiple arm apparatus and methods for separation of particles
|
US8133371B2
(en)
|
2004-02-02 |
2012-03-13 |
The University Of British Columbia |
Scodaphoresis and methods and apparatus for moving and concentrating particles
|
US8529744B2
(en)
|
2004-02-02 |
2013-09-10 |
Boreal Genomics Corp. |
Enrichment of nucleic acid targets
|
US10337054B2
(en)
|
2004-02-02 |
2019-07-02 |
Quantum-Si Incorporated |
Enrichment of nucleic acid targets
|
US20080026950A1
(en)
*
|
2004-02-24 |
2008-01-31 |
Mitsubishi Rayon Co., Ltd. |
Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
|
US20080241827A1
(en)
*
|
2004-05-10 |
2008-10-02 |
Exact Sciences Corporation |
Methods For Detecting A Mutant Nucleic Acid
|
US7709194B2
(en)
*
|
2004-06-04 |
2010-05-04 |
The Chinese University Of Hong Kong |
Marker for prenatal diagnosis and monitoring
|
US7981607B2
(en)
|
2004-08-27 |
2011-07-19 |
Esoterix Genetic Laboratories LLC |
Method for detecting recombinant event
|
US8024128B2
(en)
*
|
2004-09-07 |
2011-09-20 |
Gene Security Network, Inc. |
System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data
|
WO2006047787A2
(en)
|
2004-10-27 |
2006-05-04 |
Exact Sciences Corporation |
Method for monitoring disease progression or recurrence
|
US11105808B2
(en)
|
2004-11-12 |
2021-08-31 |
Health Discovery Corporation |
Methods for screening, predicting and monitoring prostate cancer
|
CA2598217A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Marsha A. Moses |
Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin
|
EP1866647B1
(en)
*
|
2005-04-01 |
2015-04-22 |
Medvet Science Pty. Ltd. |
A method of diagnosis and treatment and agents useful for same
|
US20070196820A1
(en)
|
2005-04-05 |
2007-08-23 |
Ravi Kapur |
Devices and methods for enrichment and alteration of cells and other particles
|
US20070026418A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Martin Fuchs |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
WO2007044071A2
(en)
*
|
2005-04-21 |
2007-04-19 |
Exact Sciences Corporation |
Analysis of heterogeneous nucleic acid samples
|
JP2008543277A
(ja)
*
|
2005-05-11 |
2008-12-04 |
ジェネティック テクノロジーズ リミテッド |
胎児細胞を富化する方法
|
WO2007044091A2
(en)
*
|
2005-06-02 |
2007-04-19 |
Fluidigm Corporation |
Analysis using microfluidic partitioning devices
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US10083273B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US8515679B2
(en)
*
|
2005-12-06 |
2013-08-20 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US10081839B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US20070178501A1
(en)
*
|
2005-12-06 |
2007-08-02 |
Matthew Rabinowitz |
System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology
|
US8532930B2
(en)
|
2005-11-26 |
2013-09-10 |
Natera, Inc. |
Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
US20070027636A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Matthew Rabinowitz |
System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions
|
DK2385143T3
(en)
|
2006-02-02 |
2016-09-19 |
Univ Leland Stanford Junior |
Non-invasive fetal genetic screening by digital analysis
|
US7799531B2
(en)
*
|
2006-02-28 |
2010-09-21 |
University Of Louisville Research Foundation |
Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
|
US8609338B2
(en)
*
|
2006-02-28 |
2013-12-17 |
University Of Louisville Research Foundation, Inc. |
Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
|
US7901884B2
(en)
|
2006-05-03 |
2011-03-08 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis and monitoring
|
US7754428B2
(en)
|
2006-05-03 |
2010-07-13 |
The Chinese University Of Hong Kong |
Fetal methylation markers
|
US20080070792A1
(en)
|
2006-06-14 |
2008-03-20 |
Roland Stoughton |
Use of highly parallel snp genotyping for fetal diagnosis
|
US20080050739A1
(en)
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
EP2589668A1
(en)
*
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
WO2008016186A1
(fr)
*
|
2006-08-03 |
2008-02-07 |
The University Of Tokyo |
Anticorps spécifique dirigé contre l'autotaxine humaine intacte, procédé de criblage dudit anticorps et procédé et réactif destinés à l'examen d'un lymphome malin par une analyse de l'autotaxine
|
GB0616045D0
(en)
*
|
2006-08-11 |
2006-09-20 |
Univ Bristol |
Blood cell separation
|
CN101153336B
(zh)
*
|
2006-09-27 |
2011-09-07 |
香港中文大学 |
检测dna甲基化程度的方法和试剂盒
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
CN101680896A
(zh)
*
|
2007-03-27 |
2010-03-24 |
伊缪诺维亚公司 |
检测腺癌的蛋白标志/标记
|
US20100113286A1
(en)
*
|
2007-05-05 |
2010-05-06 |
Gilles Andre Lajoie |
Methods for detection of preeclampsia
|
US20100297067A1
(en)
*
|
2007-05-14 |
2010-11-25 |
The Johns Hopkins University |
Methylation markers for prostate cancer and methods of use
|
US20100112590A1
(en)
|
2007-07-23 |
2010-05-06 |
The Chinese University Of Hong Kong |
Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
|
LT2557520T
(lt)
|
2007-07-23 |
2021-05-25 |
The Chinese University Of Hong Kong |
Nukleorūgščių sekos disbalanso nustatymas
|
WO2009032781A2
(en)
|
2007-08-29 |
2009-03-12 |
Sequenom, Inc. |
Methods and compositions for universal size-specific polymerase chain reaction
|
KR20220008944A
(ko)
|
2008-01-18 |
2022-01-21 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
|
US8475641B2
(en)
|
2008-02-01 |
2013-07-02 |
The University Of British Columbia |
Methods and apparatus for particle introduction and recovery
|
MX2010008820A
(es)
*
|
2008-02-12 |
2010-09-07 |
Novartis Ag |
Metodo para aislar acidos nucleicos fetales o apoptoticos libres de celulas.
|
WO2009105531A1
(en)
*
|
2008-02-19 |
2009-08-27 |
Gene Security Network, Inc. |
Methods for cell genotyping
|
CN102016572A
(zh)
*
|
2008-03-11 |
2011-04-13 |
脲生物制剂有限公司 |
母体尿液的还原/氧化活性作为胎儿性别相关特性的指标
|
WO2009114543A2
(en)
*
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
US10996218B2
(en)
|
2008-03-11 |
2021-05-04 |
Ournextbaby Llc |
Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles
|
US8759109B2
(en)
|
2008-03-11 |
2014-06-24 |
Urobiologics Llc |
Use of female mammal's urine for determination of fetal gender related characteristics
|
WO2009146335A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Gene Security Network, Inc. |
Methods for embryo characterization and comparison
|
US20110178719A1
(en)
*
|
2008-08-04 |
2011-07-21 |
Gene Security Network, Inc. |
Methods for Allele Calling and Ploidy Calling
|
EP2329021B1
(en)
|
2008-09-16 |
2016-08-10 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
DK2562268T3
(en)
|
2008-09-20 |
2017-03-27 |
Univ Leland Stanford Junior |
Non-invasive diagnosis of fetal aneuploidy by sequencing
|
US20110159499A1
(en)
*
|
2009-11-25 |
2011-06-30 |
Quantalife, Inc. |
Methods and compositions for detecting genetic material
|
US9506119B2
(en)
|
2008-11-07 |
2016-11-29 |
Adaptive Biotechnologies Corp. |
Method of sequence determination using sequence tags
|
GB2483810B
(en)
|
2008-11-07 |
2012-09-05 |
Sequenta Inc |
Methods for correlating clonotypes with diseases in a population
|
US8748103B2
(en)
|
2008-11-07 |
2014-06-10 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US9365901B2
(en)
|
2008-11-07 |
2016-06-14 |
Adaptive Biotechnologies Corp. |
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
|
US8628927B2
(en)
|
2008-11-07 |
2014-01-14 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US9528160B2
(en)
|
2008-11-07 |
2016-12-27 |
Adaptive Biotechnolgies Corp. |
Rare clonotypes and uses thereof
|
US20100167271A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
DK2387627T3
(en)
|
2009-01-15 |
2016-07-04 |
Adaptive Biotechnologies Corp |
Adaptive immunity profiling and methods for producing monoclonal antibodies
|
DE202010018561U1
(de)
|
2009-01-21 |
2017-08-28 |
Streck Inc. |
Blutsammelröhrchen
|
US11634747B2
(en)
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
US20120101021A1
(en)
|
2009-02-06 |
2012-04-26 |
Surendra Sharma |
Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
|
DE202010018569U1
(de)
|
2009-02-18 |
2017-09-26 |
Streck Inc. |
Konservierung zellfreier Nukleinsäuren
|
CN102428191A
(zh)
*
|
2009-03-18 |
2012-04-25 |
塞昆纳姆股份有限公司 |
热稳定性内切核酸酶在产生报道分子中的应用
|
CA2795268A1
(en)
|
2009-04-21 |
2010-10-28 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
US8877028B2
(en)
|
2009-04-21 |
2014-11-04 |
The University Of British Columbia |
System and methods for detection of particles
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
CA2765949C
(en)
|
2009-06-25 |
2016-03-29 |
Fred Hutchinson Cancer Research Center |
Method of measuring adaptive immunity
|
US10017812B2
(en)
|
2010-05-18 |
2018-07-10 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
KR101117916B1
(ko)
|
2009-07-30 |
2012-02-24 |
삼성메디슨 주식회사 |
새지털 뷰를 검출하는 초음파 시스템 및 방법
|
US20110070590A1
(en)
|
2009-09-22 |
2011-03-24 |
Jan Rohozinski |
Primers and Methods for Determining RhD Zygosity
|
WO2011041485A1
(en)
|
2009-09-30 |
2011-04-07 |
Gene Security Network, Inc. |
Methods for non-invasive prenatal ploidy calling
|
EP3783110B1
(en)
*
|
2009-11-05 |
2022-11-23 |
The Chinese University Of Hong Kong |
Fetal genomic analysis from a maternal biological sample
|
WO2011057061A1
(en)
|
2009-11-06 |
2011-05-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-invasive diagnosis of graft rejection in organ transplant patients
|
ES2571104T3
(es)
*
|
2009-11-09 |
2016-05-24 |
Streck Inc |
Estabilización del ARN y extracción del ARN presente en células intactas dentro de una muestra de sangre
|
GB0921873D0
(en)
*
|
2009-12-15 |
2010-01-27 |
Cytosystems Ltd |
Assay
|
US20120288861A1
(en)
|
2009-12-21 |
2012-11-15 |
Heinz-Josef Lenz |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
EP3660165B1
(en)
|
2009-12-22 |
2023-01-04 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
WO2011075774A1
(en)
|
2009-12-23 |
2011-06-30 |
Genetic Technologies Limited |
Methods of enriching and detecting fetal nucleic acids
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
US10388403B2
(en)
|
2010-01-19 |
2019-08-20 |
Verinata Health, Inc. |
Analyzing copy number variation in the detection of cancer
|
CA2786564A1
(en)
|
2010-01-19 |
2011-07-28 |
Verinata Health, Inc. |
Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
|
GB2479471B
(en)
|
2010-01-19 |
2012-02-08 |
Verinata Health Inc |
Method for determining copy number variations
|
US9260745B2
(en)
|
2010-01-19 |
2016-02-16 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
WO2011090556A1
(en)
|
2010-01-19 |
2011-07-28 |
Verinata Health, Inc. |
Methods for determining fraction of fetal nucleic acid in maternal samples
|
US9323888B2
(en)
|
2010-01-19 |
2016-04-26 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
US20120100548A1
(en)
|
2010-10-26 |
2012-04-26 |
Verinata Health, Inc. |
Method for determining copy number variations
|
EP2526415B1
(en)
|
2010-01-19 |
2017-05-03 |
Verinata Health, Inc |
Partition defined detection methods
|
US20110312503A1
(en)
|
2010-01-23 |
2011-12-22 |
Artemis Health, Inc. |
Methods of fetal abnormality detection
|
KR101533469B1
(ko)
*
|
2010-02-03 |
2015-07-02 |
연세대학교 산학협력단 |
Ras의 Thr-144번과 Thr-148번의 인산화의 감지를 통한 암 진단 방법, 항암제 스크리닝 및 약효테스트 방법
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
WO2011146632A1
(en)
|
2010-05-18 |
2011-11-24 |
Gene Security Network Inc. |
Methods for non-invasive prenatal ploidy calling
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
KR20130041962A
(ko)
|
2010-07-23 |
2013-04-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
식작용 세포를 사용하여 질환 또는 상태를 검출하는 방법
|
MX361944B
(es)
|
2010-07-23 |
2018-12-19 |
President And Fellows Of Harvard College Star |
Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
|
AU2011280936A1
(en)
|
2010-07-23 |
2013-02-28 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
CA2806293A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting autoimmune or immune-related diseases or conditions
|
US20120034603A1
(en)
|
2010-08-06 |
2012-02-09 |
Tandem Diagnostics, Inc. |
Ligation-based detection of genetic variants
|
US20130261003A1
(en)
|
2010-08-06 |
2013-10-03 |
Ariosa Diagnostics, In. |
Ligation-based detection of genetic variants
|
US20140342940A1
(en)
|
2011-01-25 |
2014-11-20 |
Ariosa Diagnostics, Inc. |
Detection of Target Nucleic Acids using Hybridization
|
US11203786B2
(en)
|
2010-08-06 |
2021-12-21 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
US11031095B2
(en)
|
2010-08-06 |
2021-06-08 |
Ariosa Diagnostics, Inc. |
Assay systems for determination of fetal copy number variation
|
US10167508B2
(en)
|
2010-08-06 |
2019-01-01 |
Ariosa Diagnostics, Inc. |
Detection of genetic abnormalities
|
US10533223B2
(en)
|
2010-08-06 |
2020-01-14 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
US8700338B2
(en)
|
2011-01-25 |
2014-04-15 |
Ariosa Diagnosis, Inc. |
Risk calculation for evaluation of fetal aneuploidy
|
AU2011285534B2
(en)
*
|
2010-08-06 |
2015-12-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for prostate cancer and methods for their detection
|
US20130040375A1
(en)
|
2011-08-08 |
2013-02-14 |
Tandem Diagnotics, Inc. |
Assay systems for genetic analysis
|
EP2603607B1
(en)
|
2010-08-11 |
2016-04-06 |
Celula, Inc. |
Genotyping dna
|
EP2633311A4
(en)
|
2010-10-26 |
2014-05-07 |
Univ Stanford |
NON-INVASIVE F TAL GENE SCREENING BY SEQUENCING ANALYSIS
|
CL2010001419A1
(es)
*
|
2010-12-10 |
2011-04-25 |
Aquainnovo S A |
Metodo para detectar el sexo de forma prenatal en el plasma de madre, mediante el uso de la reaccion de polimerasa en cadena (pcr) humano en tiempo real.
|
RU2620959C2
(ru)
|
2010-12-22 |
2017-05-30 |
Натера, Инк. |
Способы неинвазивного пренатального установления отцовства
|
CA2823618C
(en)
|
2011-01-05 |
2022-05-24 |
The Chinese University Of Hong Kong |
Noninvasive prenatal genotyping of fetal sex chromosomes
|
US10131947B2
(en)
|
2011-01-25 |
2018-11-20 |
Ariosa Diagnostics, Inc. |
Noninvasive detection of fetal aneuploidy in egg donor pregnancies
|
US11270781B2
(en)
|
2011-01-25 |
2022-03-08 |
Ariosa Diagnostics, Inc. |
Statistical analysis for non-invasive sex chromosome aneuploidy determination
|
US9994897B2
(en)
|
2013-03-08 |
2018-06-12 |
Ariosa Diagnostics, Inc. |
Non-invasive fetal sex determination
|
US8756020B2
(en)
|
2011-01-25 |
2014-06-17 |
Ariosa Diagnostics, Inc. |
Enhanced risk probabilities using biomolecule estimations
|
WO2012109500A2
(en)
|
2011-02-09 |
2012-08-16 |
Bio-Rad Laboratories, Inc. |
Analysis of nucleic acids
|
US10900080B2
(en)
|
2011-02-24 |
2021-01-26 |
The Chinese University Of Hong Kong |
Molecular testing of multiple pregnancies
|
ES2583084T3
(es)
*
|
2011-03-11 |
2016-09-19 |
F. Hoffmann-La Roche Ag |
NNMT como marcador para la enfermedad pulmonar obstructiva crónica (EPOC)
|
WO2012123294A1
(en)
*
|
2011-03-11 |
2012-09-20 |
Roche Diagnostics Gmbh |
Apex1 as marker for chronic obstructive pulmonary disease (copd)
|
HUE057424T2
(hu)
|
2011-04-12 |
2022-05-28 |
Verinata Health Inc |
Genomfrakciók feloldása polimorfizmus-szám alkalmazásával
|
US9411937B2
(en)
|
2011-04-15 |
2016-08-09 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
WO2012145382A2
(en)
*
|
2011-04-20 |
2012-10-26 |
Traxxsson, Llc |
Measurement of pka for cancer characterization
|
JP2014513949A
(ja)
*
|
2011-04-20 |
2014-06-19 |
トラクソン・リミテッド・ライアビリティ・カンパニー |
患者における癌の診断方法
|
EP3378954B1
(en)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
WO2012151391A2
(en)
|
2011-05-04 |
2012-11-08 |
Streck, Inc. |
Inactivated virus compositions and methods of preparing such compositions
|
CA2742327A1
(en)
|
2011-05-20 |
2012-11-20 |
The University Of British Columiba |
Systems and methods for enhanced scoda
|
US20140235474A1
(en)
|
2011-06-24 |
2014-08-21 |
Sequenom, Inc. |
Methods and processes for non invasive assessment of a genetic variation
|
EP2561103B1
(en)
|
2011-06-29 |
2014-08-27 |
BGI Diagnosis Co., Ltd. |
Noninvasive detection of fetal genetic abnormality
|
US20140371083A1
(en)
|
2011-07-14 |
2014-12-18 |
Celula, Inc. |
Systems, apparatus and methods for biochemical analysis
|
US20130018700A1
(en)
*
|
2011-07-14 |
2013-01-17 |
International Business Machines Corporation |
Optimizing product portfolios under customer choice
|
WO2013015363A1
(ja)
*
|
2011-07-26 |
2013-01-31 |
独立行政法人産業技術総合研究所 |
上皮性卵巣癌マーカー検出用抗体及び上皮性卵巣癌判定方法
|
US8712697B2
(en)
|
2011-09-07 |
2014-04-29 |
Ariosa Diagnostics, Inc. |
Determination of copy number variations using binomial probability calculations
|
US10385475B2
(en)
|
2011-09-12 |
2019-08-20 |
Adaptive Biotechnologies Corp. |
Random array sequencing of low-complexity libraries
|
EP2757376A4
(en)
*
|
2011-09-15 |
2015-05-27 |
Univ Nagoya Nat Univ Corp |
MOLECULAR MARKER FOR EARLY IDENTIFICATION OF PATIENTS WITH PLEURAL MESOTHELIOMA AND RELATED EXPRESSION ANALYSIS METHOD
|
US9367663B2
(en)
|
2011-10-06 |
2016-06-14 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9984198B2
(en)
|
2011-10-06 |
2018-05-29 |
Sequenom, Inc. |
Reducing sequence read count error in assessment of complex genetic variations
|
US10196681B2
(en)
|
2011-10-06 |
2019-02-05 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
CA2850785C
(en)
|
2011-10-06 |
2022-12-13 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US10424394B2
(en)
|
2011-10-06 |
2019-09-24 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US8688388B2
(en)
|
2011-10-11 |
2014-04-01 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
ES2651612T3
(es)
|
2011-10-18 |
2018-01-29 |
Multiplicom Nv |
Diagnóstico de aneuploidía cromosómica fetal
|
AU2012325791B2
(en)
|
2011-10-21 |
2018-04-05 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
EP2788509B1
(en)
|
2011-12-09 |
2018-07-11 |
Adaptive Biotechnologies Corporation |
Diagnosis of lymphoid malignancies and minimal residual disease detection
|
US9499865B2
(en)
|
2011-12-13 |
2016-11-22 |
Adaptive Biotechnologies Corp. |
Detection and measurement of tissue-infiltrating lymphocytes
|
WO2013110007A1
(en)
*
|
2012-01-18 |
2013-07-25 |
The Trustees Of Columbia University In The City Of New York |
USE OF FATOSTATIN FOR TREATING CANCER HAVING A p53 MUTATION
|
WO2013107907A1
(en)
*
|
2012-01-20 |
2013-07-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for the prognosis of survival time of a patient suffering from a solid cancer
|
AU2013209499B2
(en)
|
2012-01-20 |
2018-05-10 |
Sequenom, Inc. |
Diagnostic processes that factor experimental conditions
|
US9238836B2
(en)
|
2012-03-30 |
2016-01-19 |
Pacific Biosciences Of California, Inc. |
Methods and compositions for sequencing modified nucleic acids
|
US9605313B2
(en)
|
2012-03-02 |
2017-03-28 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
KR101256206B1
(ko)
*
|
2012-03-02 |
2013-04-19 |
의료법인 제일의료재단 |
태아의 성별 결정을 위한 분석방법 및 장치
|
EP3372694A1
(en)
|
2012-03-05 |
2018-09-12 |
Adaptive Biotechnologies Corporation |
Determining paired immune receptor chains from frequency matched subunits
|
US20150072349A1
(en)
*
|
2012-03-16 |
2015-03-12 |
University Health Network |
Cancer Biomarkers and Methods of Use
|
PL2831279T3
(pl)
|
2012-03-26 |
2023-12-04 |
The Johns Hopkins University |
Szybkie wykrywanie aneuploidii
|
WO2013166444A2
(en)
|
2012-05-04 |
2013-11-07 |
Boreal Genomics Corp. |
Biomarker analysis using scodaphoresis
|
US9150905B2
(en)
|
2012-05-08 |
2015-10-06 |
Adaptive Biotechnologies Corporation |
Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
|
US20150301053A1
(en)
*
|
2012-05-10 |
2015-10-22 |
Eutropics Pharmaceuticals, Inc. |
Surrogate functional diagnostics test for cancer
|
US10289800B2
(en)
|
2012-05-21 |
2019-05-14 |
Ariosa Diagnostics, Inc. |
Processes for calculating phased fetal genomic sequences
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
JP2015519900A
(ja)
|
2012-05-21 |
2015-07-16 |
フリューダイム・コーポレイション |
粒子集団の単粒子解析方法及び単粒子単離方法
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US20150133450A1
(en)
|
2012-06-20 |
2015-05-14 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
US10497461B2
(en)
|
2012-06-22 |
2019-12-03 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
FR2993668B1
(fr)
*
|
2012-07-17 |
2015-07-03 |
Cisbio Bioassays |
Methode theranostique basee sur la detection de dimeres her2-her2
|
US9206417B2
(en)
|
2012-07-19 |
2015-12-08 |
Ariosa Diagnostics, Inc. |
Multiplexed sequential ligation-based detection of genetic variants
|
EP2904111B1
(en)
|
2012-10-01 |
2017-12-06 |
Adaptive Biotechnologies Corporation |
Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
|
WO2014055790A2
(en)
|
2012-10-04 |
2014-04-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US10482994B2
(en)
|
2012-10-04 |
2019-11-19 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
KR20150064211A
(ko)
*
|
2012-10-12 |
2015-06-10 |
고쿠리츠다이가쿠호징 히로사키다이가쿠 |
전립선암과 전립선 비대를 식별하기 위한 방법 및 키트
|
WO2015160439A2
(en)
|
2014-04-17 |
2015-10-22 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
WO2014064240A1
(en)
*
|
2012-10-26 |
2014-05-01 |
Institut Gustave Roussy |
Methods for predicting the sensitivity of a subject to immunotherapy
|
WO2014081953A1
(en)
|
2012-11-21 |
2014-05-30 |
Richard David J |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivatives
|
MX366911B
(es)
*
|
2012-11-28 |
2019-07-30 |
Nektar Therapeutics |
Método para evaluar y predecir la eficacia del tratamiento del cáncer de mama con un inhibidor de topoisomerasa i de acción prolongada.
|
US20130309666A1
(en)
|
2013-01-25 |
2013-11-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP2759602A1
(en)
|
2013-01-25 |
2014-07-30 |
Charité - Universitätsmedizin Berlin |
Non-invasive prenatal genetic diagnostic methods
|
US20140222512A1
(en)
*
|
2013-02-01 |
2014-08-07 |
Goodsnitch, Inc. |
Receiving, tracking and analyzing business intelligence data
|
US10126301B2
(en)
*
|
2013-02-08 |
2018-11-13 |
Institute For Myeloma & Bone Cancer Research |
Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and B-cell non-hodgkin lymphoma
|
US11585814B2
(en)
|
2013-03-09 |
2023-02-21 |
Immunis.Ai, Inc. |
Methods of detecting prostate cancer
|
EP4202441A3
(en)
|
2013-03-09 |
2023-07-26 |
Immunis.AI, Inc. |
Gene expression profile in macrophages for the diagnosis of cancer
|
EP3597774A1
(en)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
MX363345B
(es)
|
2013-03-15 |
2019-03-20 |
Univ Hong Kong Chinese |
Determinación de genomas fetales para embarazos de múltiples fetos.
|
US9340835B2
(en)
|
2013-03-15 |
2016-05-17 |
Boreal Genomics Corp. |
Method for separating homoduplexed and heteroduplexed nucleic acids
|
GB201304810D0
(en)
|
2013-03-15 |
2013-05-01 |
Isis Innovation |
Assay
|
CA2905505C
(en)
|
2013-03-15 |
2023-03-14 |
Lineage Biosciences, Inc. |
Methods of characterizing the immune repertoire by tagging and sequencing immunoglobulin or t-cell receptor nucleic acids
|
FI2981921T3
(fi)
|
2013-04-03 |
2023-03-09 |
Sequenom Inc |
Menetelmiä ja prosesseja geneettisten variaatioiden ei-invasiiviseen arviointiin
|
TWI522367B
(zh)
*
|
2013-04-12 |
2016-02-21 |
Univ Chang Gung |
Urine biomarkers are used to predict bladder and kidney cancer
|
WO2014172390A2
(en)
*
|
2013-04-15 |
2014-10-23 |
Cedars-Sinai Medical Center |
Methods for detecting cancer metastasis
|
JP2016516449A
(ja)
|
2013-05-09 |
2016-06-09 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Hlaマーカーを使用する母体血液中の胎児dna分率の決定方法
|
US20140343982A1
(en)
*
|
2013-05-14 |
2014-11-20 |
Landmark Graphics Corporation |
Methods and systems related to workflow mentoring
|
CN105264381B
(zh)
*
|
2013-05-16 |
2018-06-01 |
国立大学法人京都大学 |
用于确定癌症预后的方法
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
KR102665592B1
(ko)
|
2013-05-24 |
2024-05-21 |
시쿼넘, 인코포레이티드 |
유전적 변이의 비침습 평가를 위한 방법 및 프로세스
|
WO2014194289A1
(en)
*
|
2013-05-31 |
2014-12-04 |
Nektar Therapeutics |
Method for predicting and evaluating responsiveness to cancer treatment with dna-damaging chemotherapeutic agents
|
CA2915628C
(en)
|
2013-06-21 |
2020-04-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
FR3008096B1
(fr)
*
|
2013-07-03 |
2015-08-14 |
Gregory Raux |
Kit et methode de detection in vitro du rhesus d
|
WO2015013244A1
(en)
|
2013-07-24 |
2015-01-29 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
US10732182B2
(en)
|
2013-08-01 |
2020-08-04 |
Eutropics Pharmaceuticals, Inc. |
Method for predicting cancer sensitivity
|
US10262755B2
(en)
|
2014-04-21 |
2019-04-16 |
Natera, Inc. |
Detecting cancer mutations and aneuploidy in chromosomal segments
|
US9499870B2
(en)
|
2013-09-27 |
2016-11-22 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
US10577655B2
(en)
|
2013-09-27 |
2020-03-03 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
JP6525434B2
(ja)
|
2013-10-04 |
2019-06-05 |
セクエノム, インコーポレイテッド |
遺伝子の変異の非侵襲的な評価のための方法および処理
|
CA2925111C
(en)
|
2013-10-07 |
2024-01-16 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of chromosome alterations
|
WO2015066305A1
(en)
|
2013-10-30 |
2015-05-07 |
Eutropics Pharmaceuticals, Inc. |
Methods for determining chemosensitivity and chemotoxicity
|
KR102649364B1
(ko)
|
2013-11-07 |
2024-03-20 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
인간 마이크로바이옴 및 그의 성분의 분석을 위한 무세포 핵산
|
EP2876442A1
(en)
*
|
2013-11-22 |
2015-05-27 |
Institut de Cancérologie de l'Ouest |
Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer
|
US20160304968A1
(en)
*
|
2013-12-02 |
2016-10-20 |
Oncomed Pharmaceuticals, Inc. |
Identification of Predictive Biomarkers Associated With WNT Pathway Inhibitors
|
AU2015227054A1
(en)
|
2014-03-05 |
2016-09-22 |
Adaptive Biotechnologies Corporation |
Methods using randomer-containing synthetic molecules
|
EP3117011B1
(en)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
RU2717641C2
(ru)
|
2014-04-21 |
2020-03-24 |
Натера, Инк. |
Обнаружение мутаций и плоидности в хромосомных сегментах
|
US10133996B2
(en)
*
|
2014-04-22 |
2018-11-20 |
International Business Machines Corporation |
Object lifecycle analysis tool
|
US11783911B2
(en)
|
2014-07-30 |
2023-10-10 |
Sequenom, Inc |
Methods and processes for non-invasive assessment of genetic variations
|
WO2016040843A1
(en)
|
2014-09-11 |
2016-03-17 |
Harry Stylli |
Methods of detecting prostate cancer
|
WO2016069886A1
(en)
|
2014-10-29 |
2016-05-06 |
Adaptive Biotechnologies Corporation |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
US10246701B2
(en)
|
2014-11-14 |
2019-04-02 |
Adaptive Biotechnologies Corp. |
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
|
CN107406881B
(zh)
|
2015-01-12 |
2021-05-25 |
尤特罗皮克斯制药股份有限公司 |
用于指导癌症治疗的内容相关的诊断测试
|
US10364467B2
(en)
|
2015-01-13 |
2019-07-30 |
The Chinese University Of Hong Kong |
Using size and number aberrations in plasma DNA for detecting cancer
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
BR112017022666A8
(pt)
|
2015-04-20 |
2022-10-18 |
Tolero Pharmaceuticals Inc |
Preparando resposta à alvocidib por perfilamento mitocondrial
|
EP3294906B1
(en)
|
2015-05-11 |
2024-07-10 |
Natera, Inc. |
Methods for determining ploidy
|
TR201911032T4
(tr)
|
2015-05-18 |
2019-08-21 |
Tolero Pharmaceuticals Inc |
Artırılmış biyoyararlanıma sahip alvocıdıb ön ilaçları.
|
US11130986B2
(en)
|
2015-05-20 |
2021-09-28 |
Quantum-Si Incorporated |
Method for isolating target nucleic acid using heteroduplex binding proteins
|
ES2790533T3
(es)
|
2015-05-22 |
2020-10-28 |
Nipd Genetics Public Company Ltd |
Análisis paralelo múltiplex de regiones genómicas blanco para análisis prenatales no invasivos
|
DE102015111329B4
(de)
|
2015-07-13 |
2017-02-02 |
Bernd-Peter Ernst |
Verfahren zum Bestimmen einer relativen Häufigkeit von verschiedenen Genen oder Chromosomen eines Genoms in einer Probe
|
AU2016301315C1
(en)
|
2015-08-03 |
2022-07-07 |
Sumitomo Pharma Oncology, Inc. |
Combination therapies for treatment of cancer
|
EP3741870A1
(en)
|
2015-10-16 |
2020-11-25 |
Inguran, LLC |
Methods of genomic evaluation in livestock
|
US11377687B2
(en)
|
2015-10-16 |
2022-07-05 |
Inguran, Llc |
Methods of genomic evaluation in livestock
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
EP3402515B8
(en)
|
2016-01-12 |
2021-12-08 |
Oncotracker, Inc. |
Improved methods for monitoring immune status of a subject
|
US11708574B2
(en)
|
2016-06-10 |
2023-07-25 |
Myriad Women's Health, Inc. |
Nucleic acid sequencing adapters and uses thereof
|
WO2018002147A1
(en)
|
2016-06-30 |
2018-01-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Detection of borealin mutations for diagnosing thyroid dysgenesis
|
EP3491560A1
(en)
|
2016-07-27 |
2019-06-05 |
Sequenom, Inc. |
Genetic copy number alteration classifications
|
US11506655B2
(en)
|
2016-07-29 |
2022-11-22 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
EP3518974A4
(en)
|
2016-09-29 |
2020-05-27 |
Myriad Women's Health, Inc. |
NON-INVASIVE PRENATAL SCREENING USING DYNAMIC ITERATIVE DEEP OPTIMIZATION
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
US11274349B2
(en)
|
2016-11-08 |
2022-03-15 |
Cedars-Sinai Medical Center |
Methods for diagnosing cancer
|
WO2018094275A1
(en)
|
2016-11-18 |
2018-05-24 |
Tolero Pharmaceuticals, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
EP3362471B1
(en)
|
2016-12-19 |
2021-11-17 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Profiling peptides and methods for sensitivity profiling
|
GB2559319B
(en)
|
2016-12-23 |
2019-01-16 |
Cs Genetics Ltd |
Reagents and methods for the analysis of linked nucleic acids
|
WO2018140521A1
(en)
|
2017-01-24 |
2018-08-02 |
Sequenom, Inc. |
Methods and processes for assessment of genetic variations
|
US10894976B2
(en)
|
2017-02-21 |
2021-01-19 |
Natera, Inc. |
Compositions, methods, and kits for isolating nucleic acids
|
WO2018175907A1
(en)
|
2017-03-24 |
2018-09-27 |
Counsyl, Inc. |
Copy number variant caller
|
WO2018231944A1
(en)
|
2017-06-13 |
2018-12-20 |
Berenson James R |
Diagnostic, prognostic, and monitoring methods for solid tumor cancers
|
SK862017A3
(sk)
|
2017-08-24 |
2020-05-04 |
Grendar Marian Doc Mgr Phd |
Spôsob použitia fetálnej frakcie a chromozómovej reprezentácie pri určovaní aneuploidného stavu v neinvazívnom prenatálnom testovaní
|
US11497756B2
(en)
|
2017-09-12 |
2022-11-15 |
Sumitomo Pharma Oncology, Inc. |
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
|
AU2018355575A1
(en)
|
2017-10-27 |
2020-05-21 |
Juno Diagnostics, Inc. |
Devices, systems and methods for ultra-low volume liquid biopsy
|
US12024738B2
(en)
|
2018-04-14 |
2024-07-02 |
Natera, Inc. |
Methods for cancer detection and monitoring
|
WO2019229113A1
(en)
|
2018-05-30 |
2019-12-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Detection of tubb1 mutations for diagnosing thyroid dysgenesis
|
GB201810571D0
(en)
|
2018-06-27 |
2018-08-15 |
Cs Genetics Ltd |
Reagents and methods for the analysis of circulating microparticles
|
US11525159B2
(en)
|
2018-07-03 |
2022-12-13 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
CA3119807A1
(en)
|
2018-12-04 |
2020-06-11 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
|
WO2020191326A1
(en)
|
2019-03-20 |
2020-09-24 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Treatment of acute myeloid leukemia (aml) with venetoclax failure
|
GB201909325D0
(en)
|
2019-06-28 |
2019-08-14 |
Cs Genetics Ltd |
Reagents and methods for analysis for microparticles
|
KR20220101108A
(ko)
|
2019-10-29 |
2022-07-19 |
퀀텀-에스아이 인코포레이티드 |
유체의 연동 펌핑 및 연관 방법, 시스템, 및 디바이스
|
GB202010970D0
(en)
|
2020-07-16 |
2020-09-02 |
Immunovia Ab |
Methods, arrays and uses thereof
|